At present, the literature on the inhibitory effect of metformin on glioma stem cells mainly focuses on the studies on the AMPK-mTOR/STAT3, AMPK-FOXO3 and AMPK-P13K/AKT pathways of MET (Figure 3). The gene discussed is AKT1; the disease is central nervous system cancer.